Table 1. Distribution of cancer patients seen at Hospital Geral Dr. César Cals, from July 2011 to July 2012, according to the variables studied.
| Variables | Median (n=58) | Group 1 n (%) | Group 2 n (%) | p value* |
|---|---|---|---|---|
| Malondialdehyde (μM) | 5.00±4.07 | |||
| Normal | 21 (36.2%) | 9 (42.9) | 12 (57.1) | 0.412 |
| High | 37 (63.8%) | 20 (54.1) | 17 (45.9) | |
| Total cholesterol (mg/dL) | 163.04±172.32 | |||
| Desirable | 42 (72.4%) | 21 (50.0) | 21 (50.0) | 0.865 |
| Borderline high | 5 (8.6%) | 3 (60) | 2 (40) | |
| High | 11 (19.0%) | 5 (45.5) | 6 (54.5) | |
| HDL-c (mg/dL) | 31.70±22.74 | |||
| Low | 34 (58.6%) | 22 (64.7) | 12 (35.3) | 0.019 |
| Normal | 14 (24.2%) | 3 (21.4) | 11 (78.6) | |
| High | 10 (17.2%) | 4 (40.0) | 6 (60.0) | |
| Triacylglycerol (mg/dL) | 138.78±89.88 | |||
| Normal | 31 (53.5%) | 17 (54.8) | 14 (45.2) | 0.688 |
| Borderline | 10 (17.2%) | 4 (40.0) | 6 (60.0) | |
| High | 17 (29.3%) | 8 (47.1) | 9 (52.9) | |
| LDL-c (mg/dL) | 151.30±178.25 | |||
| Optimal | 12 (20.7%) | 6 (50.0) | 6 (50.0) | 0.296 |
| Borderline optimal | 11 (19.0%) | 3 (27.3) | 8 (72.7) | |
| Borderline high to very high | 35 (60.3%) | 20 (57.1) | 15 (42.9) |
* χ2 Test. Group 1 formed by individuals with gastrointestinal cancer; Group 2 formed by individuals with other types of cancer. HDL-c: high-density lipoprotein cholesterol; LDL-c: low-density lipoprotein cholesterol.